Pei Yuan Li (Pei-Yuan Li)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Decision Making

Helicobacter Pylori

Top Venues

Journal of digestive diseases

Disaster medicine and public health preparedness

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li
Application of furazolidone in Helicobacter pylori infection eradication. Journal of digestive diseases 25 (3) (2024)
Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li
Application of furazolidone in Helicobacter pylori infection eradication. Journal of digestive diseases (2024)
Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li
Application of furazolidone in Helicobacter pylori infection eradication. Journal of digestive diseases 25 (3) (2024)
Jia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, Su-Hong Xia, Ji-Yan Li, Ming-Yu Zhang, Kai Zhao, Li-Na Feng, Yu Zhang, Ruo-Nan Dong, Jia-Zhi Liao, Pei Yuan Li
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication. Helicobacter 28 (2) (2023)
Jia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, Su-Hong Xia, Ji-Yan Li, Ming-Yu Zhang, Kai Zhao, Li-Na Feng, Yu Zhang, Ruo-Nan Dong, Jia-Zhi Liao, Pei Yuan Li
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication. Helicobacter 28 (2) (2023)
Jia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, Su-Hong Xia, Ji-Yan Li, Ming-Yu Zhang, Kai Zhao, Li-Na Feng, Yu Zhang, Ruo-Nan Dong, Jia-Zhi Liao, Pei Yuan Li
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication. Helicobacter (2023)
Jia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, Su-Hong Xia, Ji-Yan Li, Ming-Yu Zhang, Kai Zhao, Li-Na Feng, Yu Zhang, Ruo-Nan Dong, Jia-Zhi Liao, Pei Yuan Li
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication. Helicobacter (2023)
Jia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, Su-Hong Xia, Ji-Yan Li, Ming-Yu Zhang, Kai Zhao, Li-Na Feng, Yu Zhang, Ruo-Nan Dong, Jia-Zhi Liao, Pei Yuan Li
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication. Helicobacter 28 (2) (2023)
Ying-Ying Han, Lin Zhou, Yun-Lian Hu, Xiang-Wu Ding, Hui Long, Fei Liu, Ming Xu, Zhen-Yu Zhang, Shuang-Ling Li, Qiu-Yan Wang, Cheng-Xia Su, Yan Chen, Jie Chen, Ya Lin, Pei Yuan Li
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study. Journal of gastroenterology (2023)
Jia-Lun Guan, Ge Wang, Dan Fang, Ying-Ying Han, Mu-Ru Wang, De-An Tian, Pei Yuan Li
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding? Journal of comparative effectiveness research 11 (4) (2022)
Ying-Ying Han, Hui Long, Ya Lin, Qiong He, Wei-Gang Chen, Xiang-Wu Ding, Lin Zhou, Ping An, Fen Wang, Zhen-Yu Zhang, Yun-Lian Hu, Pei Yuan Li
Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study. Helicobacter 27 (5) (2022)
Jia-Lun Guan, Yun-Lian Hu, Ping An, Qiong He, Hui Long, Lin Zhou, Zhi-Fen Chen, Jian-Guang Xiong, Shi-Sheng Wu, Xiang-Wu Ding, He-Sheng Luo, Pei Yuan Li
Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial. Pharmacotherapy 42 (3) (2022)
Ge Wang, Jia-Lun Guan, Xiu-Qing Zhu, Mu-Ru Wang, Dan Fang, Yue Wen, Meng Xie, De-An Tian, Pei Yuan Li
Infection, Screening, and Psychological Stress of Health-Care Workers With COVID-19 in a Nonfrontline Clinical Department. Disaster medicine and public health preparedness (2020)
Hai-Dan Zhu, Lian Liu, Huan Deng, Zheng-Bo Li, Jia-Qi Sheng, Xing-Xing He, De-An Tian, Pei Yuan Li
Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma. Journal of cellular physiology 235 (6) (2019)
Lian Liu, Jia-Qi Sheng, Mu-Ru Wang, Yun Gan, Xiao-Li Wu, Jia-Zhi Liao, De-An Tian, Xing-Xing He, Pei Yuan Li
Primary Cilia Blockage Promotes the Malignant Behaviors of Hepatocellular Carcinoma via Induction of Autophagy. BioMed research international 2019 (2019)
Cong Liu, Lian Liu, Hai-Dan Zhu, Jia-Qi Sheng, Xiao-Li Wu, Xing-Xing He, De-An Tian, Jia-Zhi Liao, Pei Yuan Li
Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. Scientific reports 8 (1) (2018)